Adrian Hargrave, CEO of SEEEN, explains how the Company is now funded through to profitability.  Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksERGO.L Regulatory News (ERGO)

  • There is currently no data for ERGO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

4 Apr 2017 10:50

RNS Number : 5275B
Ergomed plc
04 April 2017
 

Ergomed Plc

("Ergomed" or the "Company")

 

Director Dealing

 

Ergomed, a profitable UK-based group dedicated to the provision of specialised services to the pharmaceutical industry and the development of new drugs, announces that on 3 April 2017, Mr Peter George, Chairman of the Company, bought 100,000 ordinary shares of 1p each in the Company ("Share(s)") at a price of 190p per Share. Following this transaction, Mr Peter George holds 231,250 (0.6 per cent. of the Company's issued share capital).

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Peter George

2

Reason for the notification

a)

Position/status

Chairman

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ergomed Plc

b)

Legal Entity Identifier

213800BVS8I9VMC1AP84

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 1 pence each

 

 

 GB00BN7ZCY67

b)

Nature of the transaction

Purchase of shares

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

190p

100,000

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

 

100,000

190p

£190,000

f)

Date of the transaction

03 April 2017

g)

Place of the transaction

London Stock Exchange, AIM

 

 

Enquiries:

 

 

Ergomed Plc

Tel: +44 (0) 1483 503205

Miroslav Reljanovic (Chief Executive Officer)

Stephen Stamp (Chief Financial Officer)

 

Numis Securities (Nominated Advisor and Broker)

Tel: +44 (0) 20 7260 1000

Michael Meade / Freddie Barnfield (Nominated Adviser)

James Black (Joint Broker)

 

Stifel Nicolaus Europe Limited

Tel: +44 (0) 20 7710 7600

Jonathan Senior (Joint Broker)

 

FTI Consulting (Financial PR)

Tel: +44 (0) 20 3727 1000

Simon Conway / Mo Noonan / Natalie Garland-Collins

MC-Services - for Continental European enquiries

Tel: +49 211 52925222

Anne Hennecke

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHDMGGDLDLGNZG
Date   Source Headline
1st Mar 20217:00 amRNSTotal Voting Rights
25th Feb 20218:42 amRNSHolding(s) in Company
10th Feb 20217:00 amRNSNotice of Preliminary Results
26th Jan 20218:42 amEQSErgomed (ERGO): PrimeVigilance excels; CRO strengthened in US
26th Jan 20217:00 amRNSErgomed 2020 Trading Update
4th Jan 20217:00 amRNSTotal Voting Rights and Block Listing Return
15th Dec 20208:00 amEQSErgomed (ERGO): MedSource acquisition to boost US CRO business
14th Dec 20207:00 amRNSAcquisition of MedSource
24th Nov 20204:34 pmRNSHolding(s) in Company
18th Nov 20207:00 amRNSShare Capital Reduction Effective
11th Nov 20207:00 amRNSErgomed to Present at Jefferies Conference
2nd Nov 20207:00 amRNSTotal Voting Rights
21st Oct 20205:26 pmRNSHolding(s) in Company
19th Oct 202010:12 amRNSResult of General Meeting
12th Oct 20205:51 pmRNSHolding(s) in Company
1st Oct 20207:00 amRNSProposed Capital Reduction
1st Oct 20207:00 amRNSTotal Voting Rights
23rd Sep 20207:06 amRNSSecond Price Monitoring Extn
23rd Sep 20207:03 amRNSPrice Monitoring Extension
22nd Sep 20204:40 pmRNSSecond Price Monitoring Extn
22nd Sep 20204:35 pmRNSPrice Monitoring Extension
22nd Sep 20207:00 amRNSInterim Results
9th Sep 20201:50 pmRNSHolding(s) in Company
1st Sep 20207:00 amRNSTotal Voting Rights
20th Aug 202011:32 amRNSHolding(s) in Company
20th Aug 20207:00 amRNSNotice of Interim Results
14th Aug 20204:19 pmRNSHoldings in Company
4th Aug 20207:00 amRNSExercise of Share Options and Total Voting Rights
3rd Aug 20207:00 amRNSTotal Voting Rights
23rd Jul 20201:02 pmRNSHoldings in Company
22nd Jul 202012:57 pmRNSHolding(s) in Company
21st Jul 20202:14 pmRNSHoldings in Company
21st Jul 20202:13 pmRNSHoldings in Company
21st Jul 20207:00 amRNSErgomed H1 2020 Trading Update
20th Jul 20205:35 pmRNSHolding(s) in Company
20th Jul 20202:08 pmRNSHolding(s) in Company
17th Jul 202012:19 pmRNSHolding(s) in Company
15th Jul 202012:03 pmRNSHolding(s) in Company
6th Jul 20204:14 pmRNSExercise of Share Options and Total Voting Rights
1st Jul 20207:00 amRNSTotal Voting Rights & Block Listing Return
29th Jun 20205:17 pmRNSHoldings in Company
10th Jun 20201:43 pmEQSEdison Inv Research Limited: Edison issues flash on Ergomed (ERGO)
10th Jun 202010:53 amRNSResult of AGM
10th Jun 20207:00 amRNSAnnual General Meeting Statement
1st Jun 20207:00 amRNSTotal Voting Rights
28th May 20207:00 amRNSErgomed to Present at Jefferies Conference
18th May 20207:00 amRNSStrategic Partnership in Intelligent Automation
15th May 20207:00 amRNSNotice of AGM and Annual Report and Board Changes
1st May 20207:00 amRNSTotal Voting Rights
6th Apr 20207:00 amRNSErgomed Announces Second COVID-19 Clinical Study

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.